Mortality risk of overweight and obesity similar for blacks, whites

October 08, 2014

ATLANTA - October 08, 2014 - A study from American Cancer Society researchers finds the increased risk of premature death associated with a higher body mass index (BMI) is similar for African Americans and whites, in contrast to previous, smaller studies that indicated the association may be weaker for African Americans. The study, published in the open-access, online publication PLOS ONE, finds that among never smokers without prevalent disease, overweight and obesity are strongly associated with subsequent risk of mortality in every race. The authors say given the high prevalence of overweight and obesity among all racial-ethnic populations, and the disproportionately higher rates in African Americans among whom 35 percent are obese, the findings are of considerable clinical and public health relevance.

For the study, researchers led by Alpa V. Patel, Ph.D., analyzed data from the Cancer Prevention Study II (CPS-II), a large, prospective study. The analysis included approximately one million men and women. The study was able to address several major unresolved issues in the study of BMI and mortality. Results showed that men and women who were underweight were at higher risk of mortality as were men and women who were overweight and obese compared to normal weight men and women. The study also confirmed that smoking and prevalent disease significantly modified the association between BMI and mortality, such that the strongest associations were among never smokers without prevalent disease for men and women. In healthy never smokers, mortality rates were lowest within the upper end of the normal BMI category for all race sex groups. In addition, weight in late middle age but not older (i.e., 70 years or older) was strongly associated with future mortality. Excess body weight is known to increase risk of premature death and risk of various chronic diseases such as heart disease, diabetes, and many types of cancer.

"While recent large studies have examined the relationship between BMI and all-cause mortality in white and Asian populations in the United States, this relationship has not been well-characterized in African Americans," said Dr. Patel. "The American Cancer Society's Cancer Prevention Study-II is very well-suited to address this issue because of its large size, including nearly a million participants, and long-term follow-up of 28 years, making it the largest study to date in African Americans."
-end-
Additional co-authors on the study are Janet S. Hildebrand, MPH and Susan M. Gapstur, PhD, both of the American Cancer Society.

Article: Body mass index and all-cause mortality in a large prospective cohort of White and Black U.S. adults, Alpa V. Patel, Janet S. Hildebrand, Susan M. Gapstur; Published: October 08, 2014DOI: 10.1371/journal.pone.0109153

American Cancer Society

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.